• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
Aktis
  • Our Science
  • Our Programs
  • Our Team
  • Join Us
  • News & Events
  • Contact Us
Back to News & Media
05/22/2024

Aktis, Lilly ink $1.1B cancer radiopharmaceutical deal

SHARE
SHARE

Privacy Policy Terms & Conditions

© Aktis Oncology 2021. All Rights Reserved.

Sign up for the latest from Aktis Oncology

Contact Us

Linkedin